IL74615A - Pharmaceutical compositions comprising etoposide in oral dosage form - Google Patents

Pharmaceutical compositions comprising etoposide in oral dosage form

Info

Publication number
IL74615A
IL74615A IL74615A IL7461585A IL74615A IL 74615 A IL74615 A IL 74615A IL 74615 A IL74615 A IL 74615A IL 7461585 A IL7461585 A IL 7461585A IL 74615 A IL74615 A IL 74615A
Authority
IL
Israel
Prior art keywords
etoposide
pharmaceutical compositions
dosage form
oral dosage
oral
Prior art date
Application number
IL74615A
Other versions
IL74615A0 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IL74615A0 publication Critical patent/IL74615A0/en
Publication of IL74615A publication Critical patent/IL74615A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL74615A 1984-03-19 1985-03-15 Pharmaceutical compositions comprising etoposide in oral dosage form IL74615A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19

Publications (2)

Publication Number Publication Date
IL74615A0 IL74615A0 (en) 1985-06-30
IL74615A true IL74615A (en) 1988-07-31

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74615A IL74615A (en) 1984-03-19 1985-03-15 Pharmaceutical compositions comprising etoposide in oral dosage form

Country Status (28)

Country Link
JP (1) JPS60209516A (en)
KR (1) KR850006136A (en)
AT (1) AT392904B (en)
AU (1) AU571308B2 (en)
BE (1) BE901963A (en)
CA (1) CA1238578A (en)
CH (1) CH662731A5 (en)
DE (1) DE3509741A1 (en)
DK (1) DK164535C (en)
EG (1) EG17521A (en)
ES (1) ES8702140A1 (en)
FI (1) FI84023C (en)
FR (1) FR2561104B1 (en)
GB (1) GB2155789B (en)
GR (1) GR850688B (en)
IE (1) IE58340B1 (en)
IL (1) IL74615A (en)
IT (1) IT1187640B (en)
LU (1) LU85812A1 (en)
MY (1) MY101916A (en)
NL (1) NL8500739A (en)
NO (1) NO170569C (en)
NZ (1) NZ211078A (en)
OA (1) OA07968A (en)
PT (1) PT80131B (en)
SE (1) SE8501312L (en)
YU (1) YU45243B (en)
ZA (1) ZA851935B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (en) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd Soft capsule containing etoposide
JPS61189230A (en) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd Etoposide preparation
DE3629386A1 (en) * 1986-08-29 1988-03-03 Scherer Gmbh R P GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (en) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc Absorption promoter for large intestine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (en) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (en) * 1974-11-07 1976-05-13 Universal Oil Prod Co Engine crankcase gases treatment - by catalytic reactor in heat exchange and partial mixture with exhaust gases
FR2358144A1 (en) * 1976-07-13 1978-02-10 Lipha Compsn. for treating biliary lithiasis - contains hymecromone and chenodeoxy-cholic acid, with lower cost and better tolerance
JPS5940137B2 (en) * 1976-10-14 1984-09-28 武田薬品工業株式会社 Pharmaceutical composition for oral administration
FR2410504A1 (en) * 1977-12-05 1979-06-29 Air Liquide Safety control in chemical reactor carrying out oxidations - comprises oxygen concn. monitoring in gaseous phase and nitrogen injections if set concn. is reached
DE2809543A1 (en) * 1978-03-06 1979-09-13 Werner Henke Rendering oil or gas well gases harmless - by desulphurisation and oxidn. in catalytic reactors
JPS60239418A (en) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd Soft capsule containing etoposide

Also Published As

Publication number Publication date
MY101916A (en) 1992-02-15
CA1238578A (en) 1988-06-28
FR2561104A1 (en) 1985-09-20
NL8500739A (en) 1985-10-16
KR850006136A (en) 1985-10-02
YU45243B (en) 1992-05-28
BE901963A (en) 1985-09-18
NO170569C (en) 1992-11-04
IE58340B1 (en) 1993-09-08
GR850688B (en) 1985-07-08
DK164535C (en) 1992-11-30
GB2155789B (en) 1987-10-21
DK122285A (en) 1985-09-20
FI851040A0 (en) 1985-03-15
DE3509741A1 (en) 1985-09-26
GB8506943D0 (en) 1985-04-24
GB2155789A (en) 1985-10-02
PT80131A (en) 1985-04-01
LU85812A1 (en) 1985-12-12
CH662731A5 (en) 1987-10-30
FI84023C (en) 1991-10-10
NO851022L (en) 1985-09-20
ATA81985A (en) 1990-12-15
AU571308B2 (en) 1988-04-14
PT80131B (en) 1987-10-20
NO170569B (en) 1992-07-27
DK164535B (en) 1992-07-13
IE850686L (en) 1985-09-19
SE8501312L (en) 1985-09-20
SE8501312D0 (en) 1985-03-18
AU3897585A (en) 1985-09-26
AT392904B (en) 1991-07-10
FR2561104B1 (en) 1988-04-08
OA07968A (en) 1987-01-31
DK122285D0 (en) 1985-03-18
ES541370A0 (en) 1986-12-16
IT1187640B (en) 1987-12-23
NZ211078A (en) 1987-08-31
FI84023B (en) 1991-06-28
IT8519897A0 (en) 1985-03-14
FI851040L (en) 1985-09-20
IL74615A0 (en) 1985-06-30
EG17521A (en) 1990-06-30
JPS60209516A (en) 1985-10-22
ZA851935B (en) 1985-10-30
ES8702140A1 (en) 1986-12-16
YU42085A (en) 1988-02-29

Similar Documents

Publication Publication Date Title
GB8508452D0 (en) Pharmaceutical compositions
GB8403359D0 (en) Pharmaceutical compositions
GB8525709D0 (en) Pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
EP0163178A3 (en) Pharmaceutical composition
GB8509814D0 (en) Pharmaceutical compositions
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
GB8509813D0 (en) Pharmaceutical compositions
GB8403360D0 (en) Pharmaceutical compositions
GB8503513D0 (en) Pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
IL74615A (en) Pharmaceutical compositions comprising etoposide in oral dosage form
GB8409961D0 (en) Pharmaceutical compositions
GB8410636D0 (en) Pharmaceutical substances/compositions
GB8419245D0 (en) Medicinal compositions
GB8524054D0 (en) Pharmaceutical compositions
GB8605037D0 (en) Oral pharmaceutical compositions
IE861385L (en) Oral pharmaceutical composition
GB8427877D0 (en) Pharmaceutical compositions
GB8432199D0 (en) Pharmaceutical compositions
ZA84895B (en) Pharmaceutical compositions
IE842522L (en) Pharmaceutical compositions
IE69569L (en) Pharmaceutical compositions
GB8419244D0 (en) Pharmaceutical compositions